CureVac N.V. (CVAC)

CureVac Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	495.8	811.46	1,323	30.68	21.38
Short-Term Investments	4.49	4.65	2.62	1.46	39.25
Cash & Cash Equivalents	500.28	816.11	1,325	32.14	60.63
Cash Growth	-38.70%	-38.42%	4022.99%	-46.99%	-
Receivables	6.3	18.5	1.01	15.69	5.48
Inventory	23.99	56.16	14.53	6.2	2.95
Other Current Assets	53.46	49.24	49.1	3.15	4.01
Total Current Assets	584.03	940.02	1,390	57.18	73.07
Property, Plant & Equipment	241.7	200.39	100.59	61.69	40.47
Goodwill and Intangibles	31.78	13.24	14.15	5.7	6.21
Other Long-Term Assets	2.96	4.59	6.77	6.06	5.9
Total Long-Term Assets	276.44	218.22	121.5	73.45	52.59
Total Assets	860.47	1,158	1,511	130.62	125.66
Accounts Payable	73.46	127.7	21.69	6.48	10.91
Deferred Revenue	107.31	142.1	658.05	73.52	70.36
Current Debt	4.98	3.47	3.23	2	0.08
Other Current Liabilities	-29.53	84.47	-435.34	-53.91	-53.22
Total Current Liabilities	156.23	357.73	247.62	28.09	28.13
Long-Term Debt	37.11	25.42	52.04	77.14	0
Other Long-Term Liabilities	133.89	86.61	500.35	68.19	65.45
Total Long-Term Liabilities	170.99	112.03	552.39	145.34	65.45
Total Liabilities	327.22	469.77	800.01	173.42	93.58
Total Debt	42.09	28.89	55.28	79.15	0.08
Debt Growth	45.67%	-47.73%	-30.16%	102689.61%	-
Retained Earnings	-1,305.81	-1,056.79	-645.07	-515.95	-416.07
Comprehensive Income	-0.14	-0.03	0.06	0.02	-0.01
Shareholders' Equity	533.25	688.48	711.35	-42.8	32.08
Net Cash / Debt	458.2	787.22	1,270	-47.01	60.56
Net Cash / Debt Growth	-41.80%	-38.01%	-	-	-
Working Capital	427.8	582.29	1,142	29.09	44.94
Book Value Per Share	2.80	3.68	4.03	-0.24	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).